mizoribine has been researched along with Bile Duct Obstruction in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kamio, Y; Mori, N; Murakami, T; Yokooji, T | 1 |
| Ishiguro, M; Kamio, Y; Mori, N; Murakami, T; Shimomukai, Y; Yokooji, T | 1 |
2 other study(ies) available for mizoribine and Bile Duct Obstruction
| Article | Year |
|---|---|
Increased intestinal absorption of mizoribine, an immunosuppressive agent, in cholestatic rats.
Topics: 1-Naphthylisothiocyanate; Administration, Oral; Animals; Biological Availability; Carbon Tetrachloride; Cholestasis; Food-Drug Interactions; Immunosuppressive Agents; Intestinal Absorption; Male; Rats; Rats, Sprague-Dawley; Ribonucleosides | 2010 |
Modulation in concentrative nucleoside transporters-mediated intestinal absorption of mizoribine, an immunosuppressive agent, in lipopolysaccharide-treated rats.
Topics: Animals; Anti-Bacterial Agents; Antimetabolites, Antineoplastic; Antiviral Agents; Bile; Biological Availability; Cephalexin; Cholestasis; Chromatography, High Pressure Liquid; Deoxycytidine; Gemcitabine; Immunosuppressive Agents; In Vitro Techniques; Inflammation; Intestinal Absorption; Lipopolysaccharides; Male; Nucleoside Transport Proteins; Rats; Rats, Sprague-Dawley; Ribavirin; Ribonucleosides | 2011 |